Product Information
HYOSCYAMINE 0.125 MG TAB SL is a generic product labeled by Chartwell RX LLC, priced at $0.1707 per EA under NDC 62135085912. Its NADAC has been published 66 times since Jul 2, 2025.
Strength
.125 mg/1
Manufacturer
Chartwell RX LLCNDC
62135085912
Classification
Generic
Dosage Form
TABLET
Route
ORAL; SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
9/20/2024
Price Statistics
The NADAC for HYOSCYAMINE 0.125 MG TAB SL has been published 66 times since Jul 2, 2025, and over the history we have for it it has declined 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1707 per EA |
|---|---|
| All-time high | $0.2202 (Jul 16, 2025) |
| All-time low | $0.1707 (Sep 23, 2026) |
| 52-week high | $0.2188 |
| 52-week low | $0.1707 |
| Median price | $0.2085 |
| Average price | $0.2063 |
| Largest weekly change | -6.9% (Aug 19, 2026) |
| Weeks tracked | 66 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hyoscyamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYOSCYAMINE 0.125 MG TAB SL?
The current National Average Drug Acquisition Cost (NADAC) for HYOSCYAMINE 0.125 MG TAB SL, manufactured by Chartwell RX LLC, is $0.1707 per EA (NDC 62135085912), effective Sep 30, 2026.
How has the price of HYOSCYAMINE 0.125 MG TAB SL changed over time?
Over the history we have for it, the NADAC for HYOSCYAMINE 0.125 MG TAB SL has declined 22.5%. It has been tracked across 66 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for HYOSCYAMINE 0.125 MG TAB SL?
Since Jul 2, 2025, the NADAC for HYOSCYAMINE 0.125 MG TAB SL has ranged from a low of $0.1707 (Sep 23, 2026) to a high of $0.2202 (Jul 16, 2025), with a median of $0.2085 per EA.
Are there cheaper alternatives to HYOSCYAMINE 0.125 MG TAB SL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE 0.125 MG ODT, is $0.1442 per EA — about 15% below HYOSCYAMINE 0.125 MG TAB SL.
Who manufactures HYOSCYAMINE 0.125 MG TAB SL?
HYOSCYAMINE 0.125 MG TAB SL (NDC 62135085912) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.